您当前的位置:
首页 >
文章列表页 >
Exploring new horizons in CAR-based therapy for the treatment of thyroid-associated ophthalmopathy
LETTER TO THE EDITOR | 更新时间:2025-12-13
Exploring new horizons in CAR-based therapy for the treatment of thyroid-associated ophthalmopathy
Exploring new horizons in CAR-based therapy for the treatment of thyroid-associated ophthalmopathy
- “在xxx领域,xx专家取得了重大的研究进展。通过建立xx体系/探索xx主题/验证xx猜想,他们为解决xx问题提供了解决方案/为xx研究开辟了新方向/为xx体系的构建奠定了基础。”
- MMR 2025年12卷第8期 页码:1326-1328
DOI: 10.1186/s40779-025-00590-7
录用:2025-01-02
移动端阅览
AI导读
HTML全文
图( 1 ) 表( 0 )
参考文献
出版信息
数据统计
42
浏览量
54
下载量
0
CSCD
文章被引用时,请邮件提醒。
提交
工具集
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
相关文章
Octopus-inspired engineered bacteria with a plug-and-play surface display system achieves enhanced tumor-specific colonization and antitumor immunity
Engineered exosomes for diabetic foot ulcers: lessons learned, challenges remain
Immune microenvironment dynamics in pregnant patients with concomitant autoimmune diseases: mechanisms, challenges, and clinical significance
From RCT to mechanistic study: ATRA reverses myofibroblast activation by reprogramming glucose metabolism via HIC1 and PCK1/2 to attenuate hypertrophic scar formation
Bridging the lung cancer screening eligibility gap: evaluation of guideline applicability in asymptomatic patients
相关作者
Tuo Li
相关机构
暂无数据

